biote Corp. (BTMD)
NASDAQ: BTMD · Real-Time Price · USD
2.390
+0.010 (0.42%)
Jan 15, 2026, 4:00 PM EST - Market closed
biote Market Cap
biote has a market cap or net worth of $109.13 million as of January 16, 2026. Its market cap has decreased by -40.65% in one year.
Market Cap
109.13M
Enterprise Value
187.49M
1-Year Change
-40.65%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since April 28, 2021, biote's market cap has decreased from $390.07M to $109.13M, a decrease of -72.02%. That is a compound annual growth rate of -23.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 77.12M | -8.08% |
| Dec 31, 2025 | 83.90M | -56.37% |
| Dec 31, 2024 | 192.28M | 9.55% |
| Dec 29, 2023 | 175.51M | 333.26% |
| Dec 30, 2022 | 40.51M | -89.58% |
| Dec 31, 2021 | 388.94M | -0.29% |
| Apr 28, 2021 | 390.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |